<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03110042</url>
  </required_header>
  <id_info>
    <org_study_id>HILO-HF Registry</org_study_id>
    <nct_id>NCT03110042</nct_id>
  </id_info>
  <brief_title>HILO-HF Registry: High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure</brief_title>
  <official_title>High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The HILO-HF Registry is a single centre registry that will be performed to provide
      information on the usual baseline oxygen saturation (SpO2) in patients presenting to ED with
      a primary ED diagnosis of AHF
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Change in blood oxygen saturation levels from baseline to 72 hours</measure>
    <time_frame>72 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dyspnea on visual analogue scale (VAS) to 72 hours</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in global symptoms using Patient Global Assessment (PGA) measure to 72 hours</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Peak Expiratory Flow</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with Worsening Heart Failure</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day composite clinical event (all-cause mortality, HF readmission, days alive and out of hospital)</measure>
    <time_frame>30days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acute Heart Failure</condition>
  <arm_group>
    <arm_group_label>Observational Cohort</arm_group_label>
    <description>All patients will receive usual standard of care with the heart failure management including the routine supplemental oxygen therapy.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients &gt;40 years of age presenting to the ED with AHF
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt;40 years of age presenting to the ED with AHF

          -  With or without tested BNP

          -  With or without admission to hospital for treatment of HF\

          -  Patients must be recruited within the first 24 hours of presenting to the ED.

        Exclusion Criteria:

          -  Patients on home oxygen

          -  Patients with known prior hypercapnic failure (PaCO2&gt;50 mmHg)

          -  Asthma

          -  Primary pulmonary hypertension

          -  Patients requiring urgent positive pressure ventilation or intubation or on &gt;10 L/min
             oxygen
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nariman Sepehrvand</last_name>
    <email>hilo@ualberta.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alberta Hospital / Mazankowski Alberta Heart Institute</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Ezekowitz, MD</last_name>
      <email>hilo@ualberta.ca</email>
    </contact>
    <investigator>
      <last_name>Justin Ezekowitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2017</study_first_submitted>
  <study_first_submitted_qc>April 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <last_update_submitted>November 10, 2017</last_update_submitted>
  <last_update_submitted_qc>November 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

